The reversal effects of 3-bromopyruvate on multidrug resistance In Vitro and In Vivo derived from human breast MCF-7/ADR Cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Wu, Long ^a   Xu, Jun ^a   Yuan, Weiqi ^a   Wu, Baojian ^a   Wang, Hao ^b   Liu, Guangquan ^a   Wang, Xiaoxiong ^a   Du, Jun ^b   Cai, Shaohui ^a  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 BROMOPYRUVATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PROTEIN HISTIDINE KINASE; PROTEIN HISTIDINE KINASE 2; RHODAMINE 123; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; BROMOPYRUVATE; ENZYME INHIBITOR; PYRUVIC ACID DERIVATIVE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; MCF 7 CELL LINE; MICROPLATE READER; MONOTHERAPY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; MORTALITY; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; P-GLYCOPROTEINS; PYRUVATES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84910642981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112132     Document Type: Article

References (30)

1. Fernandes AF, Cruz A, Moreira C., Santos MC, Silva T (2014) Social Support Provided to Women Undergoing Breast Cancer Treatment: A Study Review. Advances in Breast Cancer Research 3: 47-53.
2. Aller SG, Yu J, Ward A., Weng Y, Chittaboina S, et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722.
3. Zahreddine H, Borden KL (2013) Mechanisms and insights into drug resistance in cancer. Frontiers in pharmacology 4: 1-8.
4. Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemoth Pharm 40: S3-S8.
5. Ni L-N, Li J-Y, Miao K-R, Qiao C, Zhang S-J, et al. (2011) Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol 28: 265-269.
6. Choudhuri S, Klaassen CD (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25: 231-259.
7. Natarajan K, Xie Y, Baer M.R., Ross DD (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol 83: 1084-1103.
8. Thomas H, Coley HM (2003) Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer control 10: 159-159.
9. Chen Z, Zhang H, Lu W., Huang P (2009) Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1787: 553-560.
10. Ko YH, Smith BL, Wang Y, Pomper M.G., Rini DA, et al. (2004) Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 324: 269-275.
11. Nakano A, Tsuji D, Miki H., Cui Q, El Sayed SM, et al. (2011) Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. PloS one 6: e27222.
12. Jiang G-M, He Y-W, Fang R, Zhang G., Zeng J, et al. (2010) Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels. Int J Biochem Cell B 42: 1840-1846.
13. Zhang J, Guo H, Zhang H., Wang H, Qian G, et al. (2011) Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene. Cancer 117: 86-95.
14. Marks DC, Belov L, Davey M.W., Davey RA, Kidman AD (1992) The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leukemia Res 16: 1165-1173.
15. Trivedi ER, Blumenfeld CM, Wielgos T, Pokropinski S., Dande P, et al. (2012) Multi-gram synthesis of a porphyrazine platform for cellular translocation, conjugation to Doxorubicin and cellular uptake. Tetrahedron Lett: 5475-5478.
16. Skowronek P, Haferkamp O, Rödel G (1992) A fluorescence-microscopic and flow-cytometric study of HeLa cells with an experimentally induced respiratory deficiency. Biochem Biophys Res Commun 187: 991-998.
17. Touil Y, Zuliani T, Wolowczuk I., Kuranda K, Prochazkova J, et al. (2013) The PI3K/AKT Signaling Pathway Controls the Quiescence of the Low-Rhoda-mine123-Retention Cell Compartment Enriched for Melanoma Stem Cell Activity. Stem Cells: 641-651.
18. Zhang D-M, Shu C., Chen J-J, Sodani K, Wang J., et al. (2012) BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo. Molecular pharmaceutics 9: 3147-3159.
19. Chen K, Zhang Q, Wang J., Liu F, Mi M, et al. (2009) Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res 1279: 131-138.
20. Allam AB, Brown MB, Reyes L (2012) Disruption of the S41 Peptidase Gene in Mycoplasma mycoides capri Impacts Proteome Profile, H2O2 Production, and Sensitivity to Heat Shock. PloS one 7: e51345.
21. Hayashida S, Arimoto A, Kuramoto Y., Kozako T, Honda S-i, et al. (2010) Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARα in mice. Mol Cell Biochem 339: 285-292.
22. Fang R, Zhang G, Guo Q., Ning F, Wang H, et al. (2013) Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma. Cancer Lett 333: 66-75.
23. Chen JJ, Sun YL, Tiwari A.K., Xiao ZJ, Sodani K, et al. (2012) PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter. Cancer science 103: 1531-1537.
24. Luk CK, Tannock IF (1989) Flow cytometric analysis of doxorubicin accumulation in cells from human and rodent cell lines. J Natl Cancer I 81: 55-59.
25. Shoshan MC (2012) 3-bromopyruvate: Targets and outcomes. J Bioenerg Biomembr 44: 7-15.
26. Pedersen PL (2012) 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue. J Bioenerg Biomembr 44: 1-6.
27. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy; 2009. Elsevier. pp. 5475-5478.
28. Bayley J-P, Devilee P (2012) The Warburg effect in 2012. Current opinion in oncology 24: 62-67.
29. Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann M.M., et al. (2005) Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol 70: 949-958.
30. Glare E, Divjak M, Bailey M., Walters E (2002) β-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax 57: 765-770.